Investigational Site Number 111 is a clinical research site located in Las Vegas, Nevada, United States 89135.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
Investigational Site Number 111 has participated in 1 clinical trials.
Therapeutic areas: Hemophilia A, Hemophilia B.
Sponsors: Genzyme, a Sanofi Company.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Nevada · View every site in Las Vegas
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Investigational Site Number 111 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Investigational Site Number 111 has 1 clinical trials on record. Their work covers Hemophilia A, Hemophilia B.
Investigational Site Number 111 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.